8/20/25
ieso Sharpens Focus on AI-Powered Mental Healthcare with Sale of UK Telecare Services Business
ieso is committed to building the future we’ve long envisioned: delivering safe, effective AI-powered mental healthcare at scale.
Back to Resources
Summary
ieso has sold its UK telecare services business to Mindler, a pan-European digital therapy provider, to focus fully on scaling Velora, its clinical-grade generative AI mental health program. The parent company, ieso Digital Health Limited, remains fully independent under the ieso brand. Velora is being deployed via SaaS integration into clinical workflows, with an immediate focus on the U.S. market and a global mission. CEO Kent Tangen described mental health as one of AI's most urgent and natural use cases. The transaction was advised by Cooley LLP and Artis Finance.
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--ieso, a global leader in evidence-based digital mental health, today announced the sale of its UK telecare services business to Mindler, a leading pan-European digital therapy provider. The acquisition is specific to ieso’s NHS-facing care operations in the UK, including delivery of typed and video therapy services. Mindler’s press release is available here.
"As AI adoption accelerates, mental health is emerging as one of its most urgent and natural use cases. The market is moving fast, and so are we."
- Kent Tangen, CEO, ieso
The parent company, ieso Digital Health Limited, remains fully independent and continues to operate under the ieso brand. With the sale now complete, ieso is entirely focused on scaling its clinical-grade generative AI platform, Velora, to deliver safe, effective, personalized mental health support via SaaS integration into clinical workflows.
“We’re proud to have supported thousands of lives through ieso’s UK telecare services. That legacy will always be a part of who we are,” said Kent Tangen, CEO at ieso. “With those operations now in excellent hands at Mindler, ieso is committed to building the future we’ve long envisioned: delivering safe, effective AI-powered mental healthcare at scale. Our immediate focus is in the US, but our mission is global. As AI adoption accelerates, mental health is emerging as one of its most urgent and natural use cases. The market is moving fast, and so are we.”
ieso was advised on the transaction by Cooley LLP and Artis Finance.
Read the original press release via Business Wire here.
ABOUT THE AUTHOR
Latest Articles
6/4/26
ieso Welcomes James Dold as Head of Sales
A healthcare leader with clinical roots, James Dold brings over 20 years of experience across behavioral health, value-based care, strategic partnerships, and care delivery to ieso as Head of Sales.
6/1/26
Mental Health Isn’t Separate From Women’s Health - So Why Is It Still Treated That Way?
As women’s health companies expand care services, mental health can't sit on the sidelines. Embedded support reflects the reality of how women experience their health in an interconnected and overlapping way.
5/20/26
Digital GI Care Has an ROI Ceiling. Mental Health Is How You Break Through It.
Digital GI platforms have closed major access gaps and proven real ROI. The unaddressed mental health burden in IBS and IBD populations is capping how much further those outcomes can go.
5/7/26
The Mental Health AI Market is Crowded. Evidence is Still Rare.
A new Hemingway Report market map shows conversational AI in mental health is moving fast, but clinical evidence remains the clearest differentiator.